• Company shares update of biopesticide product pipeline
• MGROF committed to combating deadly crop diseases, pests in Colombia and North America
• MustGrow touts potential additional uses as bioherbicide, sprout suppressor

MustGrow Biologics (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops and other markets, recently provided an update of its biopesticide product pipeline (https://ibn.fm/eOTGT). By extracting natural compounds from within the mustard seed — the mustard plant’s natural defense mechanism — the company has provided natural solutions to potentially replace widely used harmful synthetics that are being banned and deregistered.

As part of the update, the company reported that a U.S. EPA registration already exists for its biopesticide product in granule format for use as a preplant soil treatment for high-value crops such as fruits and vegetables. The company is now working to obtain a new registration for its biopesticide in liquid format. As with the granular biopesticide, the liquid format is also made from food-grade mustard and has the same active ingredient: AITC. The new liquid biopesticide will be called TerraMG, and MustGrow is anticipating EPA approvals this year.

TerraMG has proved effective in the control of clubroot, a disease destroying Canada’s canola crop, in laboratory and greenhouse. Clubroot spores travel easily, and currently no effective solution exists to control the disease in infected fields. Farmers have had to take extreme precautionary measures to protect against the disease; those measures include crop rotation and seeking resistant varieties of canola. Once a field is infected with clubroot, it can lead to 100% crop loss. With initial efficacy trials completed in both laboratory and greenhouse facilities, MustGrow is working to replicate the same results in field studies (https://ibn.fm/63aqj).

Canada isn’t the only country set to benefit from MustGrow’s biopesticide technology. In 2019 Colombia declared a national state of emergency due to Fusarium wilt TR4, also referred to as the Panama disease. This devastating pathogen has ravaged the $25 billion global banana industry. MustGrow has accomplished something the company believes no other agriscience team has yet to achieve: 100% control of Fusarium wilt TR4 in laboratory. Further testing will determine if the patented biopesticide technology will control the disease in field settings (https://ibn.fm/KhB2B).

As the world shifts to safer more sustainable products, synthetic herbicides face high-profile legal and regulatory challenges. The need for bioherbicides is increasing. MustGrow is using its natural mustard-derived biological approach to address this need. In the laboratory, after only 72 hours, herbicidal control was achieved using MustGrow’s products. This success led to the filing of patents for MustGrow bioherbicides. Moving forward, the company will continue to focus testing on hard to kill and herbicide-resistant weeds (https://ibn.fm/sAtJ2).

In addition to in-field application as a biopesticide and bioherbicide of MustGrow’s mustard-derived technology, MustGrow is also looking at post-harvest application for food preservation and disease and pest control. On Oct. 8, 2020, chlorpropham (“CIPC”), the leading agrochemical product for sprout suppression, was banned by the EU. With no effective treatment alternatives, potato storage sites have a major problem. MustGrow is working to create a solution and has announced an exclusive patent licensing from the University of Idaho (https://ibn.fm/Rj0bv). The mustard-derived biopesticides the company uses rely on a natural sprout inhibitor that does not contain synthetic chemicals associated with negative human health consequences.

The global biopesticide market continues to grow as the world makes the shift to ban or deregister synthetic chemicals. According to Markets and Markets, the industry is expected to double, reaching $8.5 billion by 2025. MustGrow’s safe and effective signature products hold the potential to disrupt global agriculture markets traditionally dominated by synthetic chemicals.

For more information, visit the company’s website at www.MustGrow.ca.

NOTE TO INVESTORS: The latest news and updates relating to MGROF are available in the company’s newsroom at https://ibn.fm/MGROF

• GRYN positioning itself for rapid growth in 2021
• Retaining expert counsel with innate understanding of cannabis law is necessary step as company builds highly differentiated business model
• Green Hygienics’ growth strategy includes rollout of omnichannel bricks-and-clicks program featuring multiple premium brands

As Green Hygienics Holdings (OTCQB: GRYN) wraps up its first successful crop harvest and enters the wholesale retail stage of development, the company has engaged the services of McAllister Garfield, PC, a top law firm in the industrial hemp space. GRYN, an innovative technology-driven enterprise focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids, made the decision in anticipation of rapid growth in 2021. “When lawmakers tighten the belt on hemp regulations, Green Hygienics is positioning itself to be ahead of the curve and thrive,” said Green Hygienics CEO Ron Loudoun. “Navigating regulatory compliance in an emerging industry is no small task, but a very important one to our company, and retaining counsel of such an established law firm with an innate understanding of cannabis law is a necessary step as we build out our highly differentiated business model.” In addition to retaining McAllister Garfield, part of Green Hygienics’ strategy for growth includes the rollout of an omnichannel bricks-and-clicks program featuring multiple premium brands layering over different market segments in the hemp industry. GRYN’s partnership with McAllister Garfield will provide insight and expertise in navigating regulatory compliance issues. The firm will also provide invaluable advice and support throughout the rollout, including assistance with retail opportunities. Specifically, GRYN is working with McAllister Garfield to obtain three business licenses in the downtown vicinity of San Diego for the following:

• a hemp-centric coffee house
• a smoking lounge
• An all-things-hemp dispensary and storefront

“We are pleased to be working with Green Hygienics Holdings, Inc., a promising company which puts a focus on compliance and consumer safety,” said McAllister Garfield’s hemp/CBD chairman David Wunderlich. “McAllister Garfield provides sophisticated business advice lending guidance on foundational documents, mergers and acquisitions, transactional and employment law, litigation, and administrative regulatory enforcement. Our team of lawyers has been present in the hemp industry from the very beginnings and offers a suite of solutions helping our clients through to positive outcomes as they run the regulatory gauntlet.” Green Hygienics is committed to consistently delivering safe, premium-quality products to consumers; the company is also looking to partner with CPG (consumer-packaged-goods) and pharmaceutical companies in its mission to offer hemp-based products that consumers are searching for. GRYN is focused on becoming a leader in compliances and capabilities in the hemp and cannabinoid supply marketplace. In addition, GRYN is exploring the full range of novel cannabinoids and targeted bio-delivery technologies with the objective of solving issues of stability, pharmacokinetics, biological tissue penetration and bioavailability. The company has assembled a team of visionary agrotechnology, pharmaceutical, and life scientists working at the intersection of nutraceutical, cosmeceutical and pharmaceutical technologies with the mission to improve lives. For more information, visit the company’s website at www.GreenHygienics.com. NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://ibn.fm/GRYN

• Digital connectivity and tracing innovator Loop Insights is developing contactless, digital wallet-based disruptive services in an era defined by the COVID pandemic’s distancing protocols
• During 2020, as many businesses floundered, Loop recorded its most successful year ever by forging a variety of partnerships for government and retail solutions, consumer access to healthcare information, and the rebirth of select in-person events
• Loop provided venue tracing and informational services as the tech resource for two NCAA sports bubble events during the year and is helping the travel and film industry to similarly renew productivity with minimized concerns about viral infection
• Loop’s solutions are also providing disparate governments with the ability to work together with shared information on COVID-19 medical and security protocols while maintaining their own local authority through control of their data repositories

The year 2020 was a make-or-break period for many businesses as they scrambled to continue their operations during the COVID-19 pandemic. Decisions had to be made about staffing levels, policies to protect the health of employees and customers, and how to best connect with customers and the product supply chain as a result of efforts to reduce the risk of transmitting a contagion responsible for killing or debilitating millions of people (https://ibn.fm/smlZw). Internet of Things (“IoT”) data connectivity innovator Loop Insights (TSX.V: MTRX) (OTCQB: RACMF) is celebrating its “most successful year ever” after finding itself positioned with the right product and service at the right time to capitalize on the exponential growth of highly connected consumers online as a result of the pandemic. “Throughout the year, my team and I have worked tirelessly to create products and solutions that would gain the trust of our partners … so that they could have the confidence necessary to bring this into their global customer opportunities,” Loop Insights CEO Rob Anson stated in a recap of the company’s progress (https://ibn.fm/Fvruj). “I am happy to report that we have accomplished this goal and as a result of these world-class partnerships, are now on the cusp of participating in global opportunities we never thought possible at the beginning of 2020.” Loop has deployed its digital Wallet as part of the company’s venue management platform, which provides venue-based tracing, real-time customer engagement, and AI-driven insights. As demonstrated by Loop during its deployments at two NCAA venue bubbles, the company’s platform offers a number of real-world applications that can be applied to a number of industries, including live sports, entertainment, film, travel, and many others. CEO Rob Anson also noted that a number of significant developments in 2020 will still have further implications for the company moving forward into 2021. Loop has existing partnerships with Amazon Web Services for networking with government leaders, two product partnerships with TELUS to promote its products, and an existing partnership with NTT DATA (a subsidiary of Nippon Telegraph and Telephone) that all offer significant potential for expansion. Additionally, the company’s partnership with Vend, has led to a number of retail opportunities through the company’s exposure to 25,000 stores in over 140 countries. Loop’s contactless solutions are also being employed in its Digital Connect Health Platform, which was launched this month to streamline patient interaction with medical providers. Through a simple wallet pass, patients can easily check-in for appointments, receive updates on testing, and be notified in real-time about virus tracing and other critical health information all connected by a digital ID. “The attempted implementation of wildly varying COVID-19 medical and security protocols, as well as, restriction policies by health officials and government leaders from around the world, has clearly demonstrated how divided government leaders have become by jurisdictional lines due to the lack of a single platform capable of providing uniformity and consistency in the application of policies,” Loop’s news release about the platform stated (https://ibn.fm/1OQSn). “Recognizing this breakdown, in conjunction with input from those same government leaders, Loop Insights developed the Digital Connect Health Platform to be capable of connecting Provincial and Federal systems while allowing Provinces to fully maintain their jurisdictional authority by managing their own internal data repositories.” Loop’s ability to provide governments and the private sector with the means of connecting their current legacy and antiquated systems is “so revolutionary that it has attracted the attention of global technology companies and has positioned Loop for success within healthcare,” Anson stated. For more information, visit the company’s website at www.LoopInsights.ai. NOTE TO INVESTORS: The latest news and updates relating to RACMF are available in the company’s newsroom at https://ibn.fm/RACMF

• SRAX’s Sequire will host upcoming B.Riley Securities 2021 Vision Day via its Sequire Virtual Events platform
• In addition to hosting virtual event, SRAX will also be presenting as one of bank’s top picks for 2021
• SRAX has previously hosted LD Micro Main Event on its platform, an event which featured over 250 presenting companies along with distinguished panelists, including Shaquille O’Neal and 2020 presidential candidate Brock Pierce
• As virtual conferences have proliferated in wake of COVID19, SRAX has capitalized on the growing movement via its proprietary events platform

SRAX (NASDAQ: SRAX), a financial technology company focused on unlocking data and insights for publicly traded companies through Sequire, its proprietary investor intelligence platform, has announced that it will be hosting the B.Riley Securities 2021 Vision Day via its Sequire Virtual Events platform. SRAX will also be presenting at the event as one of B.Riley’s top picks for 2021 (https://ibn.fm/EucAs). Sequire’s Virtual Events platform, which enables companies to virtually present to institutional and retail investors, is the most recent addition to Sequire’s broad suite of products and services. The events platform will complement Sequire’s preexisting functionalities, which include allowing its subscribers to track their shareholders’ selling and buying trends, search and monitor key investors, track outstanding warrants, receive the latest company specific news and media and even create and send out customized shareholder surveys designed to bring forth their stake-holders’ insights and opinions (https://ibn.fm/wQW79). “We recognize that virtual events are here to stay, and for public companies, the platform offers everything issuers need to host their meetings with maximum exposure,” stated SRAX Founder and CEO Christopher Miglino. B.Riley Securities, a leading full-service investment bank and subsidiary of B. Riley Financial, provides corporate finance, advisory, research, and sales and trading services to corporate, institutional and high net worth clients. Nationally recognized and ranked for its high quality small-cap equity research product, the investment bank also helps structure initial, secondary and follow-on offerings, carry out institutional private placements, provide merger and acquisition (M&A) advisory, and support corporate restructuring and recapitalizations. This year’s 2021 Vision Day will bring together a carefully curated group of U.S. institutional investors and senior management derived from B.Riley’s analysts’ 2021 Vision picks. The conference will feature brief company presentations which will take place in conjunction with a series of fireside chats touching upon a variety of pertinent topics, with the latter being held in 25-minute sessions and hosted by B.Riley Securities analysts. Sequire’s hosting of the B.Riley Securities 2021 Vision Day comes shortly after parent company SRAX announced the purchase of LD Micro, a leading data and event company serving the small and micro-cap space in late 2020 (https://ibn.fm/shTSU). Following the acquisition, Sequire hosted the 13th Annual LD Micro Main Event on December 14-15,2020 via its Sequire Virtual Events SaaS platform. The conference, which featured over 250 presenting companies in addition to exclusive interviews with Shaquille O’Neal and 2020 presidential candidate Brock Pierce, marked Sequire’s initial foray into virtual events and has paved the way for the platform’s future collaborations within the conference space. “With the launch of this virtual conference, we are one step closer to our mission of creating the most comprehensive platform for issuers,” said Miglino. Digital conferences have rapidly proliferated following the advent of social distancing norms and working from home statutes. SRAX, through its Sequire platform, has sought to position itself to capitalize from this movement – with the award of the B.Riley Securities Vision Day conference a glowing testament to the rising popularity of its service offering. For more information, visit the company’s website at www.SRAX.com. NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• Industry report suggests demand for copper will increase nine-fold due in part to increased production of Electric Vehicles
• S&P analysts predict copper shortages in coming years
• Josemaria is one of world’s few readily developable copper-gold projects
• Recent feasibility study concluded that Josemaria is robust, low-risk project with significant yield potential

As one industry report suggests that the increased production of electric vehicles (“EVs”) will send copper demand up nine-fold (https://ibn.fm/6dyXW), S&P analysts predict a looming copper deficit in the coming years (https://ibn.fm/0i7iV). While market forces continue to exert upward pressure on the price of copper, Josemaria Resources (TSX: JOSE) (OTCQB: JOSMF), a Canadian natural resources company based in Vancouver, British Columbia, continues to focus on its Argentine project – one of the few readily developable copper-gold projects in the world.

Copper has been used to conduct electricity since the invention of the electromagnet in the 1800s and is integral to the production and operation of EVs. A single car can contain up to 6 kilometers of copper wiring along with a substantial amount of copper in its windings, rotors and battery

As government mandates and subsidies continue to ramp up demand for EVs on a global scale, the demand for copper seems likely to increase in kind.

“Demand for electric vehicles is forecast to increase significantly over the next ten years as technology improves, the price gap with petrol cars is closed and more electric chargers are deployed,” noted IDTechEx Senior Technology Analyst Franco Gonzalez. “Our research predicts this increase will raise copper demand for electric cars and buses from 185,000 tonnes in 2017 to 1.74 million tonnes in 2027.”

Despite this increase in demand, the market for copper may not respond accordingly due to severe shortages, suggests a report by S&P Global Market Intelligence. “Beyond 2020, we forecast that consumption will outstrip production over the period to 2024, resulting in a growing refined market deficit and increasing copper prices,” said S&P Global Market Intelligence commodity analyst Thomas Rutland. “Refined production output will be hindered during this period by slowing mine production growth rates unless there is significant investment in the copper project pipeline.”

In line with expected market demand, Josemaria Resources is working rapidly to develop its flagship Josemaria Copper-Gold Project, located in the San Juan Province of Argentina. The company recently announced the results of an independent feasibility study that concluded that the property is a “robust, rapid pay-back, low-risk project” with the potential to yield an average annual metal production of 136,000 tonnes of copper, 231,000 ounces of gold and 1,164,000 ounces of silver (https://ibn.fm/kCsLF).

“We are extremely pleased with the results of the Feasibility Study at Josemaria, which indicates that this is one of the very few readily developable copper-gold projects in the world today,” said Josemaria Resources President and CEO Adam Lundin. “We believe that Josemaria is perfectly positioned to commence production by mid-decade, meeting rising copper demand from a rapidly electrifying global economy.”

Josemaria Resources is a Canadian natural resources company based in Vancouver, British Columbia. The company is part of the Lundin Group of companies, a conglomerate of 13 business entities operating in the mining, oil and gas and renewables sectors around the world.

For more information, visit the company’s website at www.JosemariaResources.com.

NOTE TO INVESTORS: The latest news and updates relating to JOSMF are available in the company’s newsroom at https://ibn.fm/JOSMF

• CYBN partners with pioneer company focused on exploring, quantifying the human mind
• Innovative Flow technology adds exciting dimension to Cybin’s commitment to develop breakthrough treatments for mental health disorders
• Innovative technology opens new frontier in psychedelic therapeutics

Cybin (NEO: CYBN), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, is partnering with neurotech pioneer HI, LLC dba Kernel to quantify brain activity in real time during psychedelic experiences (https://ibn.fm/3AG5G). CYBN plans to do this by leveraging Kernel Flow, Kernel’s breakthrough technology, for its upcoming clinical work.

“Access to Kernel’s innovative Flow technology adds another exciting dimension to the investigative work that Cybin is doing to develop breakthrough treatments for mental health disorders such as depression and addiction,” said Cybin CEO Doug Drysdale. “Currently, clinical investigators rely on limited subjective information from patients. The ability to collect quantitative data from our sponsored drug-development programs is potentially game changing in terms of our ability to measure where psychedelics work in the brain in real time, and how we ultimately design our future therapeutics.

“We are delighted to partner with Kernel to study the utility of Flow in sponsored clinical settings,” he continued. “This new cornerstone component of our sponsored clinical programs follows a record-setting capital raise, listing on the NEO Exchange and the acquisition of Adelia Therapeutics Inc., which added significant scientific capabilities, novel molecules, delivery mechanisms and intellectual property.”

In announcing the agreement, Cybin noted that the absence of the data that this partnership may provide has been a limitation in the progression of new molecules targeting neurological disorders. “Kernel’s technology opens new frontier in psychedelic therapeutics by acquiring longitudinal brain activity before, during and after a psychedelic experience, enabling quantification of what was previously subjective self-reporting,” said the company, noting that the Kernel technology is unique among brain-scanning technologies and is the first commercially scalable time-domain functional near-infrared spectroscopy system.

Based in Los Angeles, Kernel is comprised of ia team of neuroscientists, physicists, engineers, programmers, and experiment and operations experts focused on exploring and quantifying the human mind. The Kernel Flow is a head-worn, scalable, noninvasive neuroimaging system that leverages time-domain functional near-infrared spectroscopy, widely recognized as a gold standard optical method for detecting hemodynamics of the cerebral cortex.

Compared to traditional near-infrared spectroscopy devices, time-domain systems obtain richer brain signals by applying light in short pulses and precisely capturing the arrival time distribution of scattered photons from each pulse. Cybin plans to use Flow measurements as analogues of local neural activity during psychedelic experiences; the company anticipates that the quantitative measurements provided by Flow could enhance the development, delivery and scaling of its psychedelic therapeutics.

As part of the agreement, Cybin plans to take delivery of Flow in Q2 2021 and will then undertake sponsored studies in a range of clinical conditions. The company will use information, data and insights collected by Flow technology in the design of future clinical studies.

For more information, visit the company’s website at www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

• Pure Extracts commences study into psilocybin-based active treatments
• Study set to be carried out at Toronto Institute of Pharmaceutical Technology, supervised by Pure Extracts’ scientific advisor, Dr. Alexander MacGregor
• Study will delve into carrying out conformity testing, stability testing for psilocybin products thereby commencing the R&D that will ultimately take place at Pure Extracts’ purpose-built research space at its facility in British Columbia
• Functional mushroom, psychedelic drug market forecast to grow to value of $6.85 billion by 2027

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company, recently announced that it had commenced a study into the formulation and manufacturing of psilocybin-based active treatments, with oral tablets, capsules and nasal gels set to be used as investigational products. The study is set to be carried out at the Toronto Institute of Pharmaceutical Technology (“TIPT”) under the auspices of Dr Alexander MacGregor, a key scientific advisor to the Company (https://ibn.fm/Kfpwa).

The study will focus on the formulation, manufacturing and clinical bioavailability testing of rapid onset psilocybin forms – with the latter set to be used in future efficacy clinical trials that could be carried out by both Pure Extracts or its pharmaceutical customers. The study, which will adhere to both Canadian Good Manufacturing Practice and Good Clinical Practice, will delve into conformity testing and stability testing for psilocybin products while also incorporating research into processes such as clinical batch manufacturing, packaging and labelling.

“Having the support of Dr. MacGregor and TIPT, one of Canada’s premiere pharmaceutical R&D companies, while waiting to receive our Dealer’s License from Health Canada is invaluable,” commented Pure Extracts’ CEO Ben Nikolaevsky. “We are very excited to be laying the groundwork for our move into the controlled substances world of psychedelics and to be furthering our knowledge-base in psilocybin and associated novel delivery mechanisms.”

The study will be overseen by Dr. Alexander MacGregor, a pharmaceutical science inventor and expert in the field of pharmaceutical technology and novel drug delivery systems. Dr. MacGregor has successfully applied for a wide variety of global patents in the field of medical treatments and pharmaceutical drug delivery technologies, with his various innovations resulting in groundbreaking therapeutic drugs for the treatment of cancer, management of diabetes, systemic infections and post-operative pain.

In conjunction with the study, Pure Extracts revealed that the Company had begun construction on a fourth unit within its 10,000 square foot facility, designed for research and development into psilocybin and functional mushrooms as a whole (https://ibn.fm/AVxxy).

Psilocybin-based drugs have begun to gain increased acceptance as alternative treatments for major depressive disorders (“MDDs”) in the United States, with the U.S. FDA granting its initial Breakthrough Therapy designation to COMPASS Pathway’s psilocybin-assisted therapy in late 2018 (https://ibn.fm/s227G). With the functional mushroom and psychedelic drug market projected to grow at a CAGR of 16.3% over the next eight years to $6.85 billion by 2027 (https://ibn.fm/M1qj5), Pure Extracts seems to be well on its way toward enjoying a leadership position within the field.

For more information, visit the company’s website at www.PureExtractsCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to PULL are available in the company’s newsroom at https://ibn.fm/PULL

• Consumers bracing for COVID’s impact into 2022 with what is being dubbed “homebody economy”
• Pandemic has led to demand spikes, changes in consumer supply and buying patterns
• WTER has seen significant market share growth; ideally positioned to continue to expand

A recent survey indicates that consumers in a post-pandemic environment are likely to be cautious in their buying habits, as many expect continued impact moving into 2020; survey respondents indicated an estimated 40% increase in intent to purchase online (https://ibn.fm/2jmtd). (The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER) has an aggressive growth strategy that includes a direct-to-consumer, e-commerce platform— www.A88CBD.com — along with a compelling digital-marketing campaign, which place the company in a strong position in the post-COVID environment. “Consumers continue to shift to online shopping across categories, with many consumers planning to shift almost completely online after COVID-19,” reported a recent McKinsey and Company survey. “Americans are trying new digital habits and intensifying usage of digital behaviors such as grocery delivery and restaurant delivery.” These consumers are looking for both convenience and value as they search out new brands. While many Americans are eager to spend more time with family and friends, they are not eager to return to grocery stores and restaurants. What is being dubbed the “homebody economy” is expected to stick post-COVID. Around 53% of Americans believe their routines will not return to normal until well into 2021 or even later. Major shifts in consumers’ online spending focus on small businesses and e-commerce. This was seen in consumers’ online shopping patterns during Cyber Monday 2020 (with an increase in 15.1% from 2019), Small Business Saturday (with 30.2% growth) and Sunday (23.7% growth). Consumers are also focusing their purchases on groceries and health and wellness products (https://ibn.fm/9p4cd). WTER looks to be well positioned to benefit from the new buying patterns. The top bulk-alkaline-water brand is committed to strengthening its presence in the e-commerce and online grocery shopping spaces as the demand for flavored waters, sustainable packaging and CBD are leading in health, wellness and lifestyle trends. The company has two online sites: one for CBD-infused products — www.A88CBD.com — and one for its flagship beverage products — www.TheAlkalineWaterCo.com. “The pandemic has led to demand spikes and changing consumers supply and buying patterns, which we believe have finally begun to normalize,” WTER CEO Ricky Wright stated during the company’s November earnings call (https://ibn.fm/2WjTR). Wright also noted that the company had implemented aggressive promotional spending over the summer, resulting in increased market share. “According to the total U.S. all-sales channels Nielsen’s report dated October 3, our flagship brand has been the fastest-growing, non-flavored, value-added water of the top 10 brands over the last 13-, 26- and 52-week periods,” he said. “Per Nielsen’s over the last 26 weeks, our brand has grown 17.7% compared to the category growth of a negative 0.3%. Over the previous 13 weeks, our retail sales have exceeded our quarterly average. And we’re robust — 23.2% more than double the category growth. In the last 26 weeks, we have also gained roughly 0.4% market share. This is equivalent to almost $8 million in annual retail sales. During the same period our top selling SKU has become one of the top 10 in the value-added water category in the entire country. We remain the only top 10 value-added water that has grown double digits in every four-week period since January.” As one of the fastest growing alkaline water companies in the United States, WTER has continued to expand its brand. The company was able to enter the grocery and supermarket channel and provide products in more than 70,000 retail locations nationwide, including Walmart, Kroger, Albertsons, Safeway and Publix. Several single SKUs have also been introduced to these grocery stores. In addition, WTER is pursuing distribution to convenience stores, drugstores and specialty retail channels. Due to COVID, these stores have aligned their merchandise to include healthier, convenient items. Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88, is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. Quickly being recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. Additionally, in 2020, the company launched its A88CBD Infused line of ingestible and topical products, including its CBD water. For more information, visit the company’s websites at www.TheAlkalineWaterCo.com and www.A88CBD.com. NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://ibn.fm/WTER

• Global cannabidiol market expected to increase almost sixfold by 2025
• CNSC offers powerful line of CBD products under Xceptol brand
• CannAssist has forecast first-year sales of $5 million, with steady sales growth moving forward

With industry experts predicting the stabilization of hemp prices and a more predictable market in 2021 (https://ibn.fm/q7JzX), CannAssist International (OTCQB: CNSC) appears to be ideally situated in a sector forecast for remarkable growth. Owner of Xceptor Labs, CannAssist is a biotechnological pharmaceutical and wellness company that markets a powerful line of cannabidiol (“CBD”) products under the Xceptol brand.

“The hemp market’s volatility appears to be coming to an end with stabilization of hemp prices at the end of 2020,” reported a recent article titled “Greater CBD Market Stability Likely in 2021.” The Hemp Grower article continued, “Adam Koh, Hemp Benchmarks’ editorial director, tells Hemp Grower that after 12–18 months of hemp biomass prices declining, they began to stabilize this past October and even increase slightly in November. This likely foretells a more predictable market in 2021, Koh says.”

That stability, combined with projected growth of the global cannabidiol market, which was valued at $4.6 billion in 2019 and is expected to increase almost sixfold by 2025 (https://ibn.fm/cA61X), creates incredible potential for CannAssist. One of the first U.S.-based CBD companies to have its securities listed for trading on a U.S. public capital market, CannAssist is focused on offering high-quality, high-performance brands, and has several products currently under development.  Based on growing revenue from raw material and retail sales and expanding social media output and the engagement of strategic partners to help CannAssist ‘get the word out’ and growing distribution arrangements in the US and globally, licensing agreements, retail sales and the Xceptol brand’s international distribution, CannAssist has forecast first-year sales of $5 million, with steady sales growth moving forward.

The company’s products are formulated using Xceptor Labs’ exclusive technology, CiBiDinol, and a proprietary process developed by CannAssist founder Mark Palumbo. The approach addresses vital issues with oil-soluble CBD molecules including delivery, bioavailability and short shelf-life. CannAssist notes that CiBiDinol delivers CBD in a format that is more aligned with the body’s natural bioactivity, combining CBD molecules with penetration-enhancing cyclodextrin. The technology enhances CBD stability and absorption through the skin and gut.

Launched in September 2020, CannAssist’s current Xceptol product lineup includes FDA registered topical pain-cream products formulated using its proprietary CiBiDinol technology. CannAssist is eyeing potential expansion into global markets, including all of North America, Central America, South America, South Africa, the EU, the UK and the Philippines. With that expansion in mind, the company is committed to adding to its strategic manufacturing, laboratory and distribution partners establishing strategic partnerships in ingredient sourcing, manufacturing, processing, laboratory, distribution and public relations and legal representation.

Established in May 2017, CannAssist is headquartered in San Diego County, California, and markets its B2B custom and CiBiDinol raw material technology and its consumer line of cannabidiol (“CBD”) products under the Xceptol brand.

For more information, visit the company’s website at www.CannAssistInternational.com.

NOTE TO INVESTORS: The latest news and updates relating to CNSC are available in the company’s newsroom at https://ibn.fm/CNSC

• Cannabis fintech marketplace innovator MAZAKALI is helping investors and issuers navigate the hurdles of an industry experiencing renewed vitality
• A supportive presidential administration along with continued state-level legalization is serving as a boon to cannabis market interests
• Professional sports leagues have become increasingly friendly to player use, reducing or eliminating cannabis-related drug testing protocols and punishments
• Market analysts forecast global revenues of $358.8 billion by 2027, an annual growth rate of 14.3% percent over 2020’s valuation. In the United States, the industry is growing at nearly twice that rate – boasting a projected annual growth of 27% over the next five years

Cannabis marketplace facilitator MAZAKALI is anticipating a bumper year for governmental and private industry policy-making regarding the leafy green plant’s product potential. Now legal under medical supervision in 35 U.S. states and permitted for adult use in 15 states, cannabis is poised to become the best performing asset class of the decade, according to a market forecast published recently by MAZAKALI. The report, titled “Cannabis 2021: Five Things to Watch,” outlines expectations for the rise of cannabis-infused beverages in the United States, improved production of rare cannabinoids through biosynthesis, growing capital infusion, accelerating acceptance under state and local laws, and increasing openness to cannabis’ psychoactive products by world governments on a national scale (https://ibn.fm/P6UlZ). “We’re seeing a huge increase of products in the health and wellness sector and I think we’ll see more women designing cannabis products for women,” infused drinks-maker K-Zen’s CEO, Judy Yee, told Forbes in a recent report (https://ibn.fm/lZIQh). “Women will be a big force in normalizing cannabis,” she predicted. The report also notes that while the NBA is now the only major sports league that suspends players from games for cannabis use, it has also temporarily stopped testing players for the plant amid the pandemic (https://ibn.fm/v47h6). The company applauded the United Nations’ decision in December to accept a recommendation by the World Health Organization to delist cannabis from its most restrictive Schedule IV classification under international drug control treaties.  Its use for non-medical and non-scientific purposes remains in that classification (https://ibn.fm/K2ZuW). The global cannabis market is expected to grow from $140.7 billion in 2020 to $358.8 billion in 2027 at a CAGR of 14.3 percent, according to the most recent Grand View Research analysis (https://ibn.fm/G0Dc9). MAZAKALI uses GreenPapers(R) such as its “Cannabis 2021” report to inform the public about cannabis markets because it believes in the concept of “Authority Through Knowledge” when it comes to helping a company maneuver through the hurdles modern-day market regulations can present on the path to profitability. The company is based in San Francisco and has been supporting cannabis businesses in raising capital and investors in placing capital since 2016. MAZAKALI’s experienced and licensed professionals deliver services to investors that include an online investment marketplace to handle direct investments in a diverse field of vetted opportunities, personalized portfolio management for highly funded clients, and an Outsourced Cannabis Investment Officer (“OCIO”) service to institutions seeking advice on their cannabis portfolio allocation practices. MAZAKALI’s services to issuers include direction through the capital-raising process on a stage-by-stage basis, following them from early preparations through offering structure, modeling, pitch preparation and launch. The company’s intuitive digital interface enables companies to pursue their ambitions with ease and confidence. For more information, visit the company’s website at www.MAZAKALI.com. NOTE TO INVESTORS: The latest news and updates relating to MAZAKALI are available in the company’s newsroom at https://ibn.fm/MAZAKALI